POLAND – The European Bank for Reconstruction and Development (EBRD) is providing Polish largest pharmaceuticals producer Polpharma with a PLN 200 million (EUR 45 million) loan for general and corporate purposes including in-house R&D activities, green investments and ESG strategy. Investment in new technologies will unlock the development of new substances and products in currently unavailable niches. The EBRD loan will also be used for the implementation of a “Go green” modernization programme aimed at minimizing the environmental and climate impact of the company’s operations. Generating more energy from renewable…
Read MorePoland’s Polpharma gets a major financial loan from the European Bank for Reconstruction and Development
